Project Grant R56NS134119

Award Date 7/8/25
Completion Date 6/30/26
Dollars Obligated $545K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43205, USA
Similar Awards
The Regents of the University of Colorado, Denver received a $155,201 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports the development of new tools to visualize and manipulate the TUBB3 tubulin isotype in living cells, which is essential for understanding the architectural complexity and signaling efficiency of...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $190,485 to Trustees of Indiana University, doing business as Indiana University Indianapolis, to conduct research into the molecular mechanisms underlying differentiation failure in neuroepithelial stem cells with NF2 gene mutations. The research aims to identify the cellular...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $637,820 to the Research Institute at Nationwide Children's Hospital to conduct forward genetic analysis of cortical circuits and structure in the mammalian neocortex. The research aims to identify novel genes responsible for proper development of the cerebral cortex and basal...
This Project Grant award of $703,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports preclinical development of a micro-tuberin gene therapy for Tuberous Sclerosis Complex Type 2. The research is being conducted by the Research Institute at Nationwide Children's Hospital, a non-profit medical research organization, over a period from Apr 1, 2025 to Mar 31, 2027. As part of this project, the Research Institute has issued a $673,064...
This federal Project Grant award of $426,650 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) aims to develop a hybrid strategy for rapidly generating region-specific neural progenitor cells and oligodendrocytes from human pluripotent stem cells. The grant, awarded to Trustees of Tufts College, will focus on leveraging Sox10 transcription factor induction to efficiently...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders", is funding research at Duke University to investigate the role of human-specific non-coding genomic sequences in regulating RNA splicing during cortical development and their implications for neurological diseases. The $147,656 award, granted on June 16, 2025, supports a research...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $676,388 to St. Jude Children's Research Hospital Inc. to conduct research on how polarity signals coordinate neuronal differentiation and nuclear organization. The key aims of the research are to define how the proteins SIAH2 and PARD6A regulate chromatin compaction and nuclear...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding research to investigate the role of the RHOBTB2 gene in Developmental and Epileptic Encephalopathies (DEEs). The $277,500 award to St. Jude Children's Research Hospital Inc. aims to develop a better understanding of the molecular and cellular consequences of pathogenic...
This federal Project Grant award for $142,452.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The funding supports research to develop novel mRNA-based gene therapies for the treatment of diffuse midline glioma (DMG), a lethal pediatric brain tumor. The principal investigator will optimize the delivery of mRNA using lipid nanoparticles to target the...
This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding research to understand how tubulin gene mutations cause malformations in brain development. The $545,081 award to the Research Institute at Nationwide Children's Hospital will support three specific aims: 1) determining the sites of expression for key tubulin genes, 2) investigating the cellular and embryonic mechanisms of phenotypes caused by mutations in certain tubulin genes, and 3) examining the unique requirements for two tubulin genes (TUBB2A and TUBB2B) in mouse neural development. The research aims to elucidate the underlying causes of "tubulinopathies," or severe brain development disorders linked to tubulin gene variants, in order to inform potential therapeutic interventions. The project period runs from July 2025 through June 2026.

Generated 8/5/25, 6:44 AM